Safety of combining PDE5 inhibitors and nitratesSome studies have demonstrated lower mortality with phosphodiesterase-5 inhibitor treatment for erectile dysfunction in men with stable coronary artery disease, compared with no treatment. POP QUIZ: Abrysvo for RSV preventionPfizer’s respiratory syncytial virus (RSV) vaccine, Abrysvo (RSV stabilized prefusion F subunit vaccine), is now available in Canada. Which statement about Abrysvo is false? Five tips for keeping pediatric patients safe in community practice Evidence suggests that errors in pediatric prescriptions are three times more likely to cause harm compared to those related to adults. GLP-1 agonists and suicidality Cases of suicidality have been reported among patients using GLP-1 receptor agonists for diabetes and/or obesity. Does melatonin have any effect on the development or progression of AMD? Study examines the association between melatonin supplementation and the risk of the development or progression of age-related macular degeneration. Does long-term use of low-dose ASA affect the incidence or progression of AMD? Study examines whether low-dose daily acetylsalicylic acid (ASA) prevents the development or progression of age-related macular degeneration (AMD). Psychedelic drug MDMA faces questions as U.S. FDA considers approval for PTSD In their assessment, FDA scientists said that patients who received MDMA and talk therapy showed ‘rapid, clinically meaningful, durable improvements in their PTSD symptoms.’ New prescribing rules for narcotics and controlled substances in Manitoba Prescription transfers between pharmacies are now permitted. This is your brain on belief: How you feel about a drug may influence its effects on your brain Participants’ beliefs about the strength of nicotine they consumed influenced their brain activity, the study showed. Drug news—May 2024 A review of new launches, new indications, new dosage forms and Health Canada advisories. First Previous 39 40 41 42 43 Next Last
